All Stories

  1. Is Medicare Advantage Advertising Helping or Hurting Patients Receiving Dialysis?
  2. Care Continuity, Nephrologists’ Dialysis Facility Preferences, and Outcomes
  3. Preoperative Kt/Vurea and Postoperative Outcomes in Patients on Maintenance Hemodialysis
  4. Examining chronic kidney disease screening frequency among diabetics: a POMDP approach
  5. Cataract Surgery in the Medicare Merit-Based Incentive Payment System
  6. Disparities in the Timing of Preoperative Hemodialysis Among Patients With End-Stage Kidney Disease
  7. On the path to individualizing care with incremental-start hemodialysis
  8. Nephrology and the US News and World Report Hospital-Based Specialty Rankings
  9. Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease—Reply
  10. Functional and Safety Outcomes of Carotid Artery Stenting and Mechanical Thrombectomy for Large Vessel Occlusion Ischemic Stroke With Tandem Lesions
  11. How Frequently Should We Screen for Hepatitis C in US Hemodialysis Centers? Evaluating the Cost-Effectiveness of Different Strategies
  12. Association Between Nephrologist Ownership of Dialysis Facilities and Clinical Outcomes
  13. Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study
  14. APOL1 Genotype, Proteinuria, and the Risk of Kidney Failure: A Secondary Analysis of the AASK (African American Study of Kidney Disease and Hypertension) and CRIC (Chronic Renal Insufficiency Cohort) Studies
  15. Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease
  16. A Blueprint for Assessing Affordability of SGLT2 Inhibitors in the United States
  17. The New Kidney-Focused Companies: A Privatized Approach to Value-Based Care and Addressing Social Determinants of Health
  18. Is Home Dialysis the Way Forward for Medicare? Assessing Potential Cost Savings Associated with Peritoneal Dialysis
  19. Author Correction: Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
  20. Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
  21. Medicare Advantage Plans Pay Large Markups To Consolidated Dialysis Organizations
  22. Patient Frailty and Functional Use of Hemodialysis Vascular Access: A Retrospective Study of the US Renal Data System
  23. Time to Invest in the Future: Assessing the Cost-Effectiveness of Empagliflozin in Diabetic Kidney Disease
  24. Health Policy Trends in Kidney Disease
  25. Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis
  26. Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 2015
  27. Payment for Dialysis Services in the Individual Market
  28. The Cost of Transferring Dialysis Care From the Employer-Based Market to Medicare
  29. Development of the Elective Outpatient Percutaneous Coronary Intervention Episode–Based Cost Measure
  30. Hospitalizations among adults with chronic kidney disease in the United States: A cohort study
  31. Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database
  32. What the Comprehensive ESRD Care Program Tells Us About the Advancing American Kidney Health Initiative
  33. The “Advancing American Kidney Health” Executive Order: Challenges and Opportunities for the Large Dialysis Organizations
  34. Competing with a pandemic: Trends in research design in a time of Covid-19
  35. Payer Mix Among Patients Receiving Dialysis
  36. Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak
  37. Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal Dialysis
  38. Four years into MACRA: What has changed?
  39. The dialysis care‐policy issue: Guest Editors’ introductory remarks
  40. Conflicts of interest in dialysis: A barrier to policy reforms
  41. Calcimimetics and Bundled Reimbursement
  42. Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis
  43. Health insurance in hemodialysis vascular access
  44. Addressing Financial Disincentives to Improve CKD Care
  45. Palliative Care Disincentives in CKD: Changing Policy to Improve CKD Care
  46. Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study
  47. Development of a Radiation Oncology Resident Continuity Clinic to Improve Clinical Competency and Patient Compliance
  48. The Medicare Access and CHIP Reauthorization Act: Implications for Nephrology
  49. Home Dialysis in the Prospective Payment System Era
  50. Re‐evaluation of re‐hospitalization and rehabilitation in renal research
  51. Early Rehospitalization After Kidney Transplantation: Assessing Preventability and Prognosis
  52. Overtreatment of Enterococcal Bacteriuria
  53. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
  54. The Role of Thromboelastography in Directing Blood Product Usage in Infant Open Heart Surgery
  55. Oncolytic viral therapies